170 related articles for article (PubMed ID: 37937613)
1. In vivo efficacy of turmeric (Curcuma longa L.) in the treatment of peripheral neuropathy: A systematic review of animal models.
Silveira RS; Baldoni AO; Couto RO; Mendonça TS; Domingueti CP
An Acad Bras Cienc; 2023; 95(3):e20200447. PubMed ID: 37937613
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic effect of turmeric on radiodermatitis: A systematic review.
Ostadi A; Arab-Zozani M; Zarei E; Ferns GA; Bahrami A
Physiol Rep; 2023 Mar; 11(5):e15624. PubMed ID: 36872842
[TBL] [Abstract][Full Text] [Related]
3. A review of therapeutic potentials of turmeric (Curcuma longa) and its active constituent, curcumin, on inflammatory disorders, pain, and their related patents.
Razavi BM; Ghasemzadeh Rahbardar M; Hosseinzadeh H
Phytother Res; 2021 Dec; 35(12):6489-6513. PubMed ID: 34312922
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of Turmeric Extracts and Curcumin for Alleviating the Symptoms of Joint Arthritis: A Systematic Review and Meta-Analysis of Randomized Clinical Trials.
Daily JW; Yang M; Park S
J Med Food; 2016 Aug; 19(8):717-29. PubMed ID: 27533649
[TBL] [Abstract][Full Text] [Related]
5. Safety and Efficacy of Turmeric (Curcuma longa) Extract and Curcumin Supplements in Musculoskeletal Health: A Systematic Review and Meta-Analysis.
Doyle L; Desomayanandam P; Bhuvanendran A; Thanawala S; Shah R; Somepalli V; Bachu S
Altern Ther Health Med; 2023 Sep; 29(6):12-24. PubMed ID: 37574203
[TBL] [Abstract][Full Text] [Related]
6. Role of Turmeric and Curcumin in Prevention and Treatment of Chronic Diseases: Lessons Learned from Clinical Trials.
Kunnumakkara AB; Hegde M; Parama D; Girisa S; Kumar A; Daimary UD; Garodia P; Yenisetti SC; Oommen OV; Aggarwal BB
ACS Pharmacol Transl Sci; 2023 Apr; 6(4):447-518. PubMed ID: 37082752
[TBL] [Abstract][Full Text] [Related]
7. Effects of turmeric (Curcuma longa) and its constituent (curcumin) on the metabolic syndrome: An updated review.
Vafaeipour Z; Razavi BM; Hosseinzadeh H
J Integr Med; 2022 May; 20(3):193-203. PubMed ID: 35292209
[TBL] [Abstract][Full Text] [Related]
8. Plant-derived medicines for neuropathies: a comprehensive review of clinical evidence.
Ebrahimi F; Farzaei MH; Bahramsoltani R; Heydari M; Naderinia K; Rahimi R
Rev Neurosci; 2019 Jul; 30(6):671-684. PubMed ID: 30768427
[TBL] [Abstract][Full Text] [Related]
9. Effects of Turmeric (Curcuma longa) on Skin Health: A Systematic Review of the Clinical Evidence.
Vaughn AR; Branum A; Sivamani RK
Phytother Res; 2016 Aug; 30(8):1243-64. PubMed ID: 27213821
[TBL] [Abstract][Full Text] [Related]
10. Oral turmeric/curcumin effects on inflammatory markers in chronic inflammatory diseases: A systematic review and meta-analysis of randomized controlled trials.
White CM; Pasupuleti V; Roman YM; Li Y; Hernandez AV
Pharmacol Res; 2019 Aug; 146():104280. PubMed ID: 31121255
[TBL] [Abstract][Full Text] [Related]
11. The Use of Curcumin for the Treatment of Renal Disorders: A Systematic Review of Randomized Controlled Trials.
Bagherniya M; Soleimani D; Rouhani MH; Askari G; Sathyapalan T; Sahebkar A
Adv Exp Med Biol; 2021; 1291():327-343. PubMed ID: 34331699
[TBL] [Abstract][Full Text] [Related]
12. Curcumin and Curcuma longa Extract in the Treatment of 10 Types of Autoimmune Diseases: A Systematic Review and Meta-Analysis of 31 Randomized Controlled Trials.
Zeng L; Yang T; Yang K; Yu G; Li J; Xiang W; Chen H
Front Immunol; 2022; 13():896476. PubMed ID: 35979355
[TBL] [Abstract][Full Text] [Related]
13. The golden spice curcumin in cancer: A perspective on finalized clinical trials during the last 10 years.
Karaboga Arslan AK; Uzunhisarcıklı E; Yerer MB; Bishayee A
J Cancer Res Ther; 2022; 18(1):19-26. PubMed ID: 35381757
[TBL] [Abstract][Full Text] [Related]
14. Turmeric (Curcuma longa) attenuates food allergy symptoms by regulating type 1/type 2 helper T cells (Th1/Th2) balance in a mouse model of food allergy.
Shin HS; See HJ; Jung SY; Choi DW; Kwon DA; Bae MJ; Sung KS; Shon DH
J Ethnopharmacol; 2015 Dec; 175():21-9. PubMed ID: 26342520
[TBL] [Abstract][Full Text] [Related]
15. Turmeric (Curcuma longa) and its major constituent (curcumin) as nontoxic and safe substances: Review.
Soleimani V; Sahebkar A; Hosseinzadeh H
Phytother Res; 2018 Jun; 32(6):985-995. PubMed ID: 29480523
[TBL] [Abstract][Full Text] [Related]
16. Antioxidant and anti-inflammatory effects of curcumin/turmeric supplementation in adults: A GRADE-assessed systematic review and dose-response meta-analysis of randomized controlled trials.
Dehzad MJ; Ghalandari H; Nouri M; Askarpour M
Cytokine; 2023 Apr; 164():156144. PubMed ID: 36804260
[TBL] [Abstract][Full Text] [Related]
17. Curcumin for the Treatment of Prostate Diseases: A Systematic Review of Controlled Clinical Trials.
Bagherniya M; Askari G; Alikiaii B; Abbasi S; Soleimani D; Sathyapalan T; Jamialahmadi T; Sahebkar A
Adv Exp Med Biol; 2021; 1291():345-362. PubMed ID: 34331700
[TBL] [Abstract][Full Text] [Related]
18. [Curcumine (Turmeric - Curcuma longa) as a Supportive Phytotherapeutic Treatment in Oncology].
Frassová Z; Rudá-Kučerová J
Klin Onkol; 2017; 31(1):15-23. PubMed ID: 29488773
[TBL] [Abstract][Full Text] [Related]
19. Multitargeting by turmeric, the golden spice: From kitchen to clinic.
Gupta SC; Sung B; Kim JH; Prasad S; Li S; Aggarwal BB
Mol Nutr Food Res; 2013 Sep; 57(9):1510-28. PubMed ID: 22887802
[TBL] [Abstract][Full Text] [Related]
20. NTP Toxicology and Carcinogenesis Studies of Turmeric Oleoresin (CAS No. 8024-37-1) (Major Component 79%-85% Curcumin, CAS No. 458-37-7) in F344/N Rats and B6C3F1 Mice (Feed Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1993 Aug; 427():1-275. PubMed ID: 12616304
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
